<SEC-DOCUMENT>0001213900-22-080156.txt : 20221215
<SEC-HEADER>0001213900-22-080156.hdr.sgml : 20221215
<ACCEPTANCE-DATETIME>20221215165715
ACCESSION NUMBER:		0001213900-22-080156
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20221215
DATE AS OF CHANGE:		20221215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Peraso Inc.
		CENTRAL INDEX KEY:			0000890394
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				770291941
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268814
		FILM NUMBER:		221465492

	BUSINESS ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131
		BUSINESS PHONE:		408 418 7500

	MAIL ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MoSys, Inc.
		DATE OF NAME CHANGE:	20060530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MONOLITHIC SYSTEM TECHNOLOGY INC
		DATE OF NAME CHANGE:	19960613
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>ea170067-s1_perasoinc.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Dec 15 21:50:16 UTC 2022 -->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:prso="http://www.perasoinc.com/20221215" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: center"><b>As filed with the Securities and Exchange
Commission on December 15, 2022</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: right"><b>Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: right"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">S-1</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>REGISTRATION STATEMENT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>UNDER THE SECURITIES ACT OF 1933</i></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>PERASO INC.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its
charter)</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top"><td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="width: 2%; text-align: center">&#160;</td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3674</b></span></td> <td style="width: 2%; text-align: center">&#160;</td> <td style="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><b>77-0291941</b></ix:nonNumeric>&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of<br/>
incorporation or organization)</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary Standard Industrial<br/>
Classification Code Number)</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<br/>
Identification Number)</span></td></tr> </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>2309 Bering Dr.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>San Jose, California 95131</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Tel: (408) 418-7500</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address, including zip code, and telephone
number, including area code, of registrant&#8217;s principal executive offices)</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>James Sullivan</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Chief Financial Officer</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Peraso Inc.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>2309 Bering Dr.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>San Jose, California 95131</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Tel: (408) 418-7500</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><i>Copies to:</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Blake Baron, Esq.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Mitchell Silberberg &amp; Knupp LLP</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>437 Madison Ave., 25th Floor<br/>
New York, NY 10022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Tel: (917) 546 7709</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>Approximate date of commencement of proposed
sale to the public</b>: As soon as practicable after this registration statement is declared effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If any of the securities being registered
on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following
box: <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If this Form is a post-effective amendment
filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If this Form is a post-effective amendment
filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number
of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr><td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer</span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer</span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr> <td><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company</span></td> <td style="vertical-align: top"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> <td><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 8pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b>The registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section 8(a), may determine.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"><span style="font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: red">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: red">The information in this preliminary
prospectus is not complete and may be changed. The Selling Stockholder may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and
we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted.</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: red"><b>SUBJECT TO COMPLETION, DATED
DECEMBER 15, 2022</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: red"><b>PRELIMINARY PROSPECTUS</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><img alt="" src="image_001.jpg"/></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>3,675,000 Shares of Common Stock issuable
upon exercise of the Purchase Warrants</b></p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This prospectus relates
to the resale of up to an aggregate of 3,675,000 shares of our common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;),
issuable upon the exercise of the purchase warrants (&#8220;Purchase Warrants&#8221;) by Armistice Capital Master Fund Ltd., a Cayman
Islands exempted company (the &#8220;Selling Stockholder&#8221;), that were issued pursuant to a Securities Purchase Agreement (the &#8220;Purchase
Agreement&#8221;), dated November 28, 2022, between the Company and the Selling Stockholder.</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We will not receive any
proceeds from the sale of the Common Stock covered by this prospectus by the Selling Stockholder. All net proceeds from the sale of the
Common Stock covered by this prospectus will go to the Selling Stockholder. See &#8220;Use of Proceeds.&#8221;</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Selling Stockholder
may sell all or a portion of the Common Stock covered by this prospectus from time to time in market transactions through any market on
which our shares of Common Stock are then traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined
by the then prevailing market price or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal
or by a combination of such methods of sale. See &#8220;Plan of Distribution.&#8221;</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed
on the Nasdaq Capital Market under the symbol &#8220;PRSO.&#8221; On December 12, 2022, the last reported sale price of our Common Stock
was $1.05.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><b>Investing in our shares
of Common Stock involves a high degree of risk. Before buying any shares of Common Stock, you should review carefully the risks and uncertainties
described under the heading </b>&#8220;<b>Risk Factors</b>&#8221; <b>section beginning on page 6 of this prospectus and in the documents
incorporated by reference into this prospectus.</b></p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><b>Neither the Securities
and Exchange Commission (</b>&#8220;<b>SEC</b>&#8221;<b>) nor any other regulatory body has approved or disapproved of these securities
or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</b></p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The date of this prospectus is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2022.</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 95%"><a href="#p_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</span></a></td>
    <td style="width: 5%; text-align: center">ii</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</span></a></td>
    <td style="text-align: center">6</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</span></a></td>
    <td style="text-align: center">9</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRIVATE OFFFERING OF <span style="text-decoration:underline">PURCHASE WARRANTS</span></span></a></td>
    <td style="text-align: center">10</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</span></a></td>
    <td style="text-align: center">12</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND POLICY</span></a></td>
    <td style="text-align: center">12</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLING STOCKHOLDER</span></a></td>
    <td style="text-align: center">16</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</span></a></td>
    <td style="text-align: center">13</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLING STOCKHOLDER</span></a></td>
    <td style="text-align: center">16</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</span></a></td>
    <td style="text-align: center">17</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</span></a></td>
    <td style="text-align: center">19</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</span></a></td>
    <td style="text-align: center">19</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#p_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</span></a></td>
    <td style="text-align: center">19</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#p_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</span></a></td>
    <td style="text-align: center">20</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="p_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>ABOUT THIS PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This prospectus is part
of a registration statement that we filed with the SEC. As permitted by the rules and regulations of the SEC, the registration statement
filed by us includes additional information not contained in this prospectus. You may read the registration statement and the other reports
we file with the SEC at the SEC&#8217;s website described below under the heading &#8220;Where You Can Find More Information.&#8221;</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Neither we nor the Selling
Stockholder have authorized anyone to provide you with information different from that contained in this prospectus, any amendment or
supplement to this prospectus or any free writing prospectus prepared by us or on our behalf. Neither we nor the Selling Stockholder take
any responsibility for, or can provide any assurance as to the reliability of, any information other than the information contained in
this prospectus, any amendment or supplement to this prospectus or any free writing prospectus prepared by us or on our behalf. We and
the Selling Stockholder are offering to sell, and seeking offers to buy, shares of our Common Stock only in jurisdictions where offers
and sales are permitted. You should assume that the information appearing in this prospectus or in any free writing prospectus prepared
by us is accurate only as of their respective dates or on the date or dates which are specified in such documents. Our business, financial
condition, results of operations and prospects may have changed since those dates.</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Neither we nor the Selling
Stockholder are offering to sell or seeking offers to purchase these securities in any jurisdiction where the offer or sale is not permitted.
We have not done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action
for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus
must inform themselves about, and observe any restrictions relating to, the offering of the securities as to distribution of the prospectus
outside of the United States.</p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Unless the context otherwise
requires, references to &#8220;Peraso,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or the &#8220;Company&#8221; in this
prospectus mean Peraso Inc. and its consolidated subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<a id="p_002"></a><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PROSPECTUS SUMMARY</b></p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><i>The following summary
highlights information contained elsewhere in this prospectus and does not contain all of the information that you should consider in
making your investment decision. Before investing in our securities, you should read this entire prospectus carefully, including the section
entitled &#8220;Risk Factors&#8221; included elsewhere in this prospectus, and the documents incorporated by reference herein, including
the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations&#8221; and our financial statements and the related notes thereto, in the documents incorporated by reference herein. Some
of the statements in this prospectus and in the documents incorporated by reference herein, constitute forward-looking statements. See
&#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221;</i>&#160;</p>

<p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; "><b>Overview</b></p>

<p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; ">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; ">Peraso Inc., together
with its subsidiaries (&#8220;Peraso,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a
fabless semiconductor company&#160;<span style="color: #231F20">focused on the development and sale of: i) semiconductor devices and modules
based on our proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual
property, or IP. Our primary focus&#160;</span>is the development of millimeter wavelength, or mmWave, wireless technology, for the 60
Gigahertz, or GHz, spectrum and for 5G cellular networks, or 5G.&#160;<span style="color: #231F20">Our&#160;mmWave&#160;products enable
a range of applications, such as 5G with low latency and high reliability, as well as multi-gigabit, mmWave links over 25 kilometers.
Our mmWave product address consumer applications,&#160;such as wireless&#160;video streaming and untethered&#160;augmented reality and
virtual reality, or&#160;AR/VR.&#160;We also have a line of memory-denominated integrated circuits&#160;</span>for high-speed cloud networking,
communications, security appliance, video, monitor and test, data center and computing markets that deliver time-to-market, performance,
power, area and economic benefits for system original equipment manufacturers, or OEMs.</p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; "><b>Business Combination</b></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; ">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; "><span>We
were formerly known as MoSys, Inc., or MoSys. On September 14, 2021, we and our subsidiaries, 2864552 Ontario Inc. and 2864555 Ontario
Inc., entered into an Arrangement Agreement, or the Arrangement Agreement, with Peraso Technologies Inc., or Peraso Tech, a privately-held
corporation existing under the laws of the province of Ontario, to acquire all of the issued and outstanding common shares of Peraso Tech,
or the Peraso Shares, including those Peraso Shares to be issued in connection with the conversion or exchange of secured convertible
debentures and common share purchase warrants of Peraso Tech, as applicable, by way of a statutory plan of arrangement, or the Arrangement,
under the Business Corporations Act (Ontario).</span>&#160;On December 17, 2021,&#160;following the satisfaction of the closing conditions
set forth in the Arrangement Agreement, the Arrangement was completed,<span>&#160;and&#160;</span>we changed
our name from MoSys to &#8220;Peraso Inc.&#8221; and began trading on The Nasdaq Stock Market, or the Nasdaq, under the symbol &#8220;PRSO.&#8221;
Certain previous shareholders of Peraso Tech elected to convert their common stock of Peraso Tech into exchangeable shares in 2864555
Ontario Inc., one of our wholly-owned subsidiaries. These exchangeable shares, which can be converted into Common Stock of ours at the
option of the holder, are similar in substance to our Common Stock.</p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; "><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; "><b>Our Products</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; "><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">We are a fabless semiconductor
company specializing in the development of millimeter wave, or mmWave, which is generally described as the frequency band from 24 Gigahertz,
GHz, to 300GHz, wireless technology. We derive revenue from selling our 60GHz and 5G semiconductor devices and modules and performance
of non-recurring engineering services. We also manufacture and sell high-performance memory semiconductor devices for a wide range of
markets and receive royalties from licensees of our memory technology.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">Our primary business focus is
on the development and sale of our mmWave wireless technology. mmWave is generally described as the frequency&#160;band from 24 GHz to
300 GHz. There are two industry standards&#160;that incorporate mmWave technology for&#160;wireless communications: (1)&#160;IEEE 802.11ad/ay;&#160;and
(2) 3GPP Release 15-17 (commonly referred to as 5G). PerasoTech has developed and continues to develop products that conform to these
standards. To date, we have not sold a minimal amount of 5G products.</p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; color: #231F20"><i>mmWave&#160;ICs</i></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">Our first&#160;mmWave&#160;product
line operated in the&#160;60 GHz band and conformed to the IEEE 802.11ad standard. This product line included a baseband IC, several&#160;variations
of mmWave radio frequency, or RF, ICs, as well as associated antenna technology.&#160;The second product line is currently in development
and addresses&#160;the 5G mmWave opportunity.&#160;Given our extensive experience in the development of mmWave technology, 5G mmWave,
is a logical adjacent market.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">The first
market that was targeted was the 60GHz IEEE 802.11ad market. Our 60GHz IEEE802.11ad products had two very important advantages over
traditional 2.4GHz / 5GHz&#160;Wi-Fi products: very&#160;high data rates (up to 4.5 Gb/s) and low latency (less than 5ms). The first
application that had traction was outdoor broadband. This included applications such as point-to-point, or PtP, backhaul links or
fixed wireless access using point-to-multipoint links, or PtMP. Products using the 60GHz band are for this market. Since the
spectrum is unlicensed (free), wireless carriers can provide services without having to spend significantly on wireless
spectrum.&#160;We are&#160;a leading supplier of semiconductors in the PtP and PtMP markets. We are currently shipping to leading
equipment suppliers in this space, as well as directly to service providers who are building their&#160;own equipment. We believe we
bring certain advantages to the market. First, our products support the spectrum from 66 GHz to 71 GHz. These are often referred to
as channels 5 and 6 in the 802.11ad/ay specifications. The key advantage in supporting these channels is&#160;that&#160;the signals
are able to propagate much further than channels 1-4; this is a result of significantly lower oxygen absorption at frequencies above
66 GHz. To date, our customers have achieved links in the range of 25 kilometers, which is substantially longer than any 60 GHz
links in the past.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">In the indoor area,
the 802.11ad technology is ideal for high speed, low latency video applications. In an indoor situation, our products can support 3 Gb/s
links with under 5ms of latency. Example applications include:</p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">AR/VR&#160;links&#160;between&#160;the&#160;headset&#160;and
the&#160;video&#160;console;</td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">USB&#160;video&#160;cameras&#160;for&#160;corporate&#160;video&#160;conferencing;</td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">Wireless&#160;security&#160;cameras;&#160;and</td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; color: #231F20; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">Smart&#160;factory&#160;safety&#160;and surveillance.</td>
</tr></table>

<p style="text-align: justify; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">We&#160;are&#160;a
leader in the manufacturing of mmWave devices and have pioneered a high-volume mmWave production test methodology using standard low cost
production test equipment. It has taken us several years to refine performance of this production test&#160;methodology, and we believe
this places us in a leadership position in address operational challenges of delivering mmWave products into high-volume markets.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left; color: #231F20"><i>Modules</i></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">In the second half
of 2021,&#160;we&#160;augmented our business model to produce and sell complete mmWave modules. The primary advantage provided by a module
is the silicon and the antenna are integrated into a single device. A differentiating characteristic of mmWave technology&#160;is that
the RF amplifiers must be as close as possible to the antenna to minimize loss.&#160;By providing&#160;a module,&#160;Peraso&#160;can
guarantee&#160;the&#160;performance&#160;of amplifier/antenna interface&#160;which simplifies the RF design engineering, facilitating
more&#160;opportunities for new companies that have not provided RF type systems as well as shortening the time to market for new products.
It&#160;is possible for third parties to provide module products, but, because we have significant, proprietary mmWave antenna IP, we
can provide a highly-competitive solution as we own and produce the module components.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; color: #231F20">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in; color: #231F20"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><i>Acceleration and other IC products</i></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">Our memory products comprise our Accelerator
Engine ICs, which include our Bandwidth Engine and&#160;quad-partition rate SRAM memory ICs.</p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-decoration:underline">Bandwidth Engine</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">The Bandwidth Engine is a memory-dominated IC
that was designed to be a high-performance companion IC to packet processors and is targeted for high-performance applications where throughput
is critical. While the Bandwidth Engine primarily functions as a memory device with a high-performance and high-efficiency interface,
it also can accelerate certain processing operations by serving as a co-processor element. Our Bandwidth Engine ICs combine: (1)&#160;our
proprietary high-density, high-speed, low latency embedded memory, (2)&#160;our high-speed serial interface technology, or SerDes, (3)&#160;an
open-standard interface protocol and (4)&#160;intelligent access technology. We believe an IC combining our 1T-SRAM memory and serial
interface with logic and other intelligence functions provides a system-level solution and significantly improves overall system performance
at lower cost, size and power consumption. Our Bandwidth Engine ICs can provide up to and over 6.5&#160;billion memory accesses per second
externally and 12&#160;billion memory accesses per second internally, which we believe is more than three times the performance of current
memory-based solutions. They also can enable system designers to significantly narrow the gap between processor and memory IC performance.
Our customers that design Bandwidth Engine ICs onto the line cards in their systems will re-architect their systems at the line-card level
and use our product to replace traditional memory solutions. When compared with existing commercially available solutions, our Bandwidth
Engine ICs may:</p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">provide
up to four times the performance;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">reduce
power consumption by approximately 50%;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">reduce
cost by greater than 50%; and</span></td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">result
in a dramatic reduction in IC pin counts on the line card.</span></td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
</span>Bandwidth Engine 2 IC products contain 576 megabits, or Mb, of memory and use a SerDes interface with up to 16 lanes operating
at up to 12.5Gbps per lane. We have been shipping our Bandwidth Engine 2 IC products since 2013. We expect these products to be a significant
revenue source for the foreseeable future.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">Our Bandwidth Engine 3 IC products contain 1152Mb
of memory and use a SerDes interface with up to 16 lanes operating at up to 25Gbps per lane. Our Bandwidth Engine 3 ICs target support
for packet-processing applications with up to five billion memory single word accesses per second, as well as burst mode to enable full
duplex buffering up to 400 Gbps for ingress, egress and oversubscription applications. The devices provide benefits of size, power, pin
count, and cost savings to our customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-decoration:underline">QPR</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">Our quad partition rate, or QPR, family of low
cost, ultra-high speed SRAM memory devices optimized for FPGA-based systems. Our QPR memory technology features an architecture that allows
for parallel accesses to multiple partitions of the memory simultaneously and allows access of up to 576 bits per read or write cycle.
The QPR device includes four independent partitions per input/output and each partition functions as a stand-alone random-access SRAM.
The high-performance interface, larger density and the multiple partitions work together to support multiple independent functional blocks
within an FPGA with one QPR device. Our MSQ220 and MSQ230 QPR devices are ideally suited for random-access applications. We also offer
an optional FPGA RTL memory controller to simplify the interface to its high capacity 567Mb or 1Gb devices. We also offer an RTL memory
controller that presents an SRAM-like interface to simplify the QPR design effort.</p>



<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">The target applications are
FPGA-based and include a broad range of markets, including test and measurement, 5G n<span style="font-family: Times New Roman, Times, Serif">etworks,
router, switching, security, computational storage, database acceleration, Big Data, aerospace and defense, advanced video, high-performance
computing, machine learning and AI and other data-driven areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">LineSpeed
Flex PHYs</span></span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
LineSpeed Flex family of 100G physical interface layer (PHY) devices are designed to support industry standards and includes gearbox,
multi-link gearbox and high density clock data recovery, or retimer devices</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Summary
of Risk Factors</b></span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
business and this offering are subject to numerous risks and uncertainties, discussed in more detail in the following section. These
risks include, among others, the following key risks:</span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><i>Risks
Related to this Offering </i></span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">You
will experience immediate and substantial dilution as a result of this offering as well as immediate dilution in the net tangible book
value per share of the Common Stock purchased in the offering.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Resale
                                            of our Common Stock in the public market may cause the market price of our Common Stock to
                                            fall.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There
                                            may be future sales of our Common Stock, which could adversely affect the market price of
                                            our Common Stock and dilute a stockholder&#8217;s ownership of Common Stock.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">You
                                            may experience future dilution as a result of future equity offerings.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
                                            substantial number of shares of our Common Stock may be sold in this offering, which could
                                            cause the price of our Common Stock to decline.</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Future
                                            sales of our Common Stock could cause our stock price to decline.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Corporate
Information</b></span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
are incorporated under the laws of the State of Delaware. Our principal corporate offices are located at 2309 Bering Drive, San Jose,
California 95131. Our telephone number is (408) 418-7500. The address of our website is www.peraso.com. The information provided on or
accessible through our website (or any other website referred to in the registration statement, of which this prospectus forms a part,
or the documents incorporated by reference herein) is not part of the registration statement, of which this prospectus forms a part,
and is not incorporated by reference as part of the registration statement, of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</div><div>


</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>The
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuer</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 79%; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peraso
    Inc.&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares offered</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,675,000
    shares of Common Stock issuable upon the exercise of the Purchase Warrants </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of common stock outstanding
    prior to this offering</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,073,912
    shares of Common Stock.&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of proceeds</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will
    not receive any proceeds from the sale of the shares of Common Stock by the Selling Stockholder. All net proceeds from the sale of
    the shares of Common Stock covered by this prospectus will go to the Selling Stockholder. See &#8220;Use of Proceeds.&#8221;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq Capital Market symbol</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Common
    Stock is listed on the Nasdaq Capital Market under the symbol &#8220;PRSO.&#8221;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk factors</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    in our Common Stock involves a high degree of risk and could result in a loss of your entire investment. See the section entitled
    &#8220;Risk Factors&#8221; of this prospectus and the section entitled &#8220;Risk Factors&#8221; in the documents incorporated by
    reference herein for a discussion of factors you should carefully consider before investing in our Common Stock.</span></td></tr>
  </table>


<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated,
the number of shares of our Common Stock outstanding prior to this offering is based on 14,073,912 shares of Common Stock outstanding
as of December 9, 2022, and excludes as of such date:</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">9,106,876
shares of Common Stock issuable upon the exchange of exchangeable shares;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">1,504,678
shares of Common Stock issuable upon exercise of outstanding stock options;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">1,370,088
shares of Common Stock issuable upon vesting of restricted stock units;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">1,438,946 shares of Common Stock available for future issuance under
the Amended and Restated 2019 Stock Incentive Plan;</p></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">33,125
shares of Common Stock issuable upon exercise of warrants dated July 2017 at $47.00 per share;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">100,771
shares of Common Stock issuable upon exercise of warrants dated October 2018 at $2.40 per share;</span></td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,150,000 shares of Common Stock issuable upon exercise of Pre-Funded Warrants at $0.01 per share; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,675,000 shares of Common Stock issuable upon exercise of Purchase Warrants at $1.36 per share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">Additionally,
unless otherwise stated, all information in this registration statement:</span></p>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">reflects
all currency in United States dollars.</span></td>
</tr></table>

<p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

</div><div>


</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><div><a id="p_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>RISK
FACTORS</b></span></p><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>Investing
in our securities includes a high degree of risk. Prior to making a decision about investing in our securities, you should consider carefully
the specific factors discussed below, together with all of the other information contained in this prospectus and the documents incorporated
by reference, including the risks identified under &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal
year ended December 31, 2021, and our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2022, June 30, 2022 and
September 30, 2022. Our business, financial condition, results of operations and prospects could be materially and adversely affected
by these risks.</i></span></p><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>Risks
Related to this Offering</b></span></p><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>It
is not possible to predict the actual number of shares we will issue under the Purchase Agreement to the Selling Stockholder, or the
actual gross proceeds resulting from exercises of Warrants for cash, if any.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
November 28, 2022, we entered into the Purchase Agreement with the Selling Stockholder, pursuant to which, among other things, we issued
Purchase Warrants to the Selling Stockholder to purchase up to 3,675,000 shares of our Common Stock with an initial exercise price of
$1.36 per share of Common Stock, exercisable beginning six months and one day from the date of the Purchase Agreement (the &#8220;Initial
Exercise Date&#8221;) for a period of five years from the Initial Exercise Date, subject to certain limitations and conditions set forth
in the Purchase Warrants. The shares of our Common Stock that may be issued under the Purchase Warrants may be issued to the Selling
Stockholder at its discretion from time to time, subject to certain limitations and conditions set forth in the Warrants.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
Selling Stockholder generally has the right to control the timing and amount of exercises of Purchase Warrants for cash, if any. Sales
of our Common Stock, if any, by the Selling Stockholder will depend upon, among other things, market conditions and other factors to
be determined by the Selling Stockholder. The Selling Stockholder may ultimately decide to sell all, some or none of the shares of our
Common Stock that may be available for potential resale. Depending on market liquidity at the time, resales of those shares by the Selling
Stockholder may cause the public trading price of our Common Stock to decrease.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Because
the Selling Stockholder has the right, under certain circumstances, to exercise the Purchase Warrants on a cashless basis (and the exercise
price thereunder is subject to adjustment, as discussed in more detail below), it is not possible for us to predict, as of the date of
this prospectus and prior to any such exercises, the number of shares of Common Stock that we will issue to the Selling Stockholder under
the Purchase Agreement, the exercise price per share that the Selling Stockholder will pay for shares upon exercise of the Purchase Warrants,
or the aggregate gross proceeds that we will receive from those exercises by the Selling Stockholder under the Purchase Agreement, if
any.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Selling Stockholder
will not be required to acquire any shares of our Common Stock if such acquisition would result in the Selling Stockholder&#8217;s beneficial
ownership exceeding 4.99% of the then issued and outstanding Common Stock.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>The
issuances of Common Stock to the Selling Stockholder upon exercise of Purchase Warrants will cause dilution to our existing stockholders,
and the sale of the shares of Common Stock acquired by the Selling Stockholder, or the perception that such sales may occur, could cause
the price of our Common Stock to fall.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">If
and when the Selling Stockholder exercises its Purchase Warrants, after the Selling Stockholder has acquired the shares, the Selling
Stockholder may resell all, some, or none of those shares at any time or from time to time in its discretion. Therefore, issuances to
the Selling Stockholder upon exercise of Purchase Warrants could result in substantial dilution to the interests of other holders of
our Common Stock. Additionally, the issuance of a substantial number of shares of our Common Stock to the Selling Stockholder, or the
anticipation of such issuances, could make it more difficult for us to sell equity or equity-related securities in the future at a time
and at a price that we might otherwise wish to effect sales.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Investors
who buy shares at different times will likely pay different prices and may experience different levels of dilution.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">If
and when the Selling Stockholder elects to sell shares of our Common Stock upon exercise of the Purchase Warrants, the Selling Stockholder
may resell all, some or none of such shares at any time or from time to time in its discretion and at different prices. As a result,
investors who purchase shares from the Selling Stockholder in this offering at different times will likely pay different prices for those
shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment
results. Investors may experience a decline in the value of the shares they purchase from the Selling Stockholder in this offering as
a result of future sales made by us to the Selling Stockholder at prices lower than the prices such investors paid for their shares in
this offering. In addition, if we sell a substantial number of shares to the Selling Stockholder under the Purchase Agreement, or if
investors expect that we will do so, the actual sales of shares or the mere existence of our arrangement with the Selling Stockholder
may make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise
wish to effect such sales.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Our
management team will have broad discretion over the use of the net proceeds from shares of Common Stock  issued to the Selling Stockholder
following its exercise of Warrants for cash, if any, and you may not agree with how we use the proceeds and the proceeds may not be invested
successfully.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management team will have
broad discretion as to the use of the net proceeds from the issuance of shares of Common Stock to the Selling Stockholder following its
exercise of Purchase Warrants for cash, if any, and we could use such proceeds for purposes other than those contemplated at the time
of commencement of this offering. Accordingly, you will be relying on the judgment of our management team with regard to the use of those
net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used
appropriately. It is possible that, pending their use, we may invest those net proceeds in a way that does not yield a favorable, or any,
return for us. The failure of our management team to use such funds effectively could have a material adverse effect on our business,
financial condition, operating results and cash flows.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>There
may be future sales of our Common Stock, which could adversely affect the market price of our Common Stock and dilute a stockholder&#8217;s
ownership of Common Stock.</i></b></span></p><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale of our Common Stock
resulting from (a) exercise of any options or vesting of restricted stock units granted to executive officers and other employees under
our equity compensation plan and (b) of any warrants, and other issuances of our Common Stock could have an adverse effect on the market
price of the shares of our Common Stock. Other than the restrictions set forth in the section titled &#8220;Plan of Distribution,&#8221;
we are not restricted from issuing additional shares of Common Stock, including any securities that are convertible into or exchangeable
for, or that represent the right to receive shares of Common Stock, provided that we are subject to the requirements of the Nasdaq Capital
Market (which generally requires stockholder approval for any transactions which would result in the issuance of more than 20% of our
then outstanding shares of Common Stock or voting rights representing over 20% of our then outstanding shares of stock). Sales of a substantial
number of shares of our Common Stock in the public market or the perception that such sales might occur could materially adversely affect
the market price of the shares of our Common Stock. Because our decision to issue securities in any future offering will depend on market
conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. Accordingly,
our stockholders bear the risk that our future offerings will reduce the market price of our Common Stock and dilute their stock holdings
in us.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Potential
volatility of the price of our Common Stock could negatively affect your investment.</i></b></span></p><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you that
there will continue to be an active trading market for our Common Stock. Historically, the stock market, as well as our Common Stock,
has experienced significant price and volume fluctuations. The closing market price for our Common Stock has varied between a high of
$5.07 on December 22, 2021, and a low of $1.05 on December 12, 2022, in the twelve-month period ended December 12, 2022. During this time,
the price per share of Common Stock has ranged from an intra-day low of $1.03 per share to an intra-day high of $5.19 per share. Market
prices of securities of technology companies can be highly volatile and frequently reach levels that bear no relationship to the operating
performance of such companies. These market prices generally are not sustainable and are subject to wide variations. If our&#160;Common&#160;Stock
trades to unsustainably high levels, it is likely that the market price of our Common Stock will thereafter experience a material decline.
As a result of fluctuations in the price of our&#160;Common&#160;Stock, you may be unable to sell your shares at or above the price you
paid for them. In addition, if we seek additional financing, including through the sale of equity or convertible securities, such sales
could cause our stock price to decline and result in dilution to existing stockholders.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>



</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the stock markets
in general, and the markets for semiconductor stocks in particular, have experienced significant volatility that has often been unrelated
to the financial condition or results of operations of particular companies. These broad market fluctuations may adversely affect the
trading price of our Common Stock and, consequently, adversely affect the price at which you could sell the shares that you purchase in
this offering. In the past, following periods of volatility in the market or significant price declines, securities class-action litigation
has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion
of management&#8217;s attention and resources, which could materially and adversely affect our business, financial condition, results
of operations and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Provisions
of our certificate of incorporation and bylaws or Delaware law might delay or prevent a change-of-control transaction and depress the
market price of our stock.</i></b></span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Various
provisions of our certificate of incorporation and bylaws might have the effect of making it more difficult for a third party to acquire,
or discouraging a third party from attempting to acquire, control of our company. These provisions could limit the price that certain
investors might be willing to pay in the future for shares of our Common Stock. Certain of these provisions eliminate cumulative voting
in the election of directors, limit the right of stockholders to call special meetings and establish specific procedures for director
nominations by stockholders and the submission of other proposals for consideration at stockholder meetings.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
are also subject to provisions of Delaware law which could delay or make more difficult a merger, tender offer or proxy contest involving
our company. In particular, Section 203 of the Delaware General Corporation Law prohibits a Delaware corporation from engaging in any
business combination with any interested stockholder for a period of three years unless specific conditions are met. Any of these provisions
could have the effect of delaying, deferring or preventing a change in control, including without limitation, discouraging a proxy contest
or making more difficult the acquisition of a substantial block of our Common Stock.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Under
our certificate of incorporation, our board of directors may issue up to a maximum of 20,000,000 shares of preferred stock without stockholder
approval on such terms as the board might determine. The rights of the holders of Common Stock will be subject to, and might be adversely
affected by, the rights of the holders of any preferred stock that might be issued in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>If
we fail to maintain compliance with the continued listing requirements of the Nasdaq Stock Market, our Common Stock may be delisted and
the price of our Common Stock and our ability to access the capital markets could be negatively impacted.</i></b></span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Our
Common Stock currently trades on the Nasdaq Stock Market under the symbol &#8220;PRSO.&#8221; This market has continued listing standards
that we must comply with in order to maintain the listing of our Common Stock. The continued listing standards include, among others,
a minimum bid price requirement of $1.00 per share and any of: (i)&#160;a minimum stockholders&#8217; equity of $2.5&#160;million; (ii)&#160;a
market value of listed securities of at least $35.0&#160;million; or (iii)&#160;net income from continuing operations of $500,000 in
the most recently completed fiscal year or in the two of the last three fiscal years. Our results of operations and fluctuating stock
price directly impact our ability to satisfy these continued listing standards. In the event we are unable to maintain these continued
listing standards, our Common Stock may be subject to delisting from the Nasdaq Stock Market.</span></p><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin: 0pt; "><span style="font-family: Times New Roman, Times, Serif">If
we were to be delisted, we would expect our Common Stock to be traded in the&#160;over-the-counter&#160;market which could adversely
affect the liquidity of our Common Stock. Additionally, we could face significant material adverse consequences, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">a
    limited availability of market quotations for our Common Stock;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a reduced
    amount of analyst coverage</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; ">a&#160;decreased
                                            ability to issue additional securities or obtain additional financing in the future;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">reduced
    liquidity for our stockholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">potential
    loss of confidence by customers, collaboration partners and employees; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">loss
    of institutional investor interest. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="p_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
NOTE REGARDING FORWARD LOOKING STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the statements in this prospectus supplement and the accompanying prospectus and the documents incorporated by reference constitute
forward-looking statements. These statements involve known and unknown risks, uncertainties, and other factors that may cause our or
our industry&#8217;s actual results, levels of activity, performance, or achievements to be materially different from any future results,
levels of activity, performance, or achievements expressed or implied by such forward-looking statements. These factors include, among
others, those incorporated by reference under &#8220;Risk Factors&#8221; below.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221;
&#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221;
&#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue&#8221; or similar terms.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Our actual results could differ materially from those expressed or implied by these forward-looking
statements as a result of various factors, including the risk factors under the section titled &#8220;Risk Factors&#8221; and a variety
of other factors, including, without limitation, statements about our future business operations and results, the market for our technology,
our strategy and competition.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
neither we nor any other person assumes responsibility for the accuracy and completeness of these statements. We undertake no obligation
to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise, except
as required by law. In light of these risks, uncertainties and assumptions, the forward-looking events discussed or incorporated by reference
in this prospectus supplement and the accompanying prospectus may not occur.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><div><a id="p_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRIVATE OFFERING OF PURCHASE WARRANTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 28, 2022, we entered into the Purchase Agreement with the Selling Stockholder pursuant to which we agreed to offer and sell
to the Selling Stockholder, in a registered direct offering, an aggregate of 1,300,000 shares (the &#8220;Shares&#8221;) of Common Stock
at a negotiated purchase price of $1.00 per Share. We also offered and sold to the Selling Stockholder pre-funded warrants to purchase
up to 1,150,000 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221;), in lieu of shares of Common Stock at the Selling Stockholder&#8217;s
election. Each Pre-Funded Warrant is exercisable for one share of Common Stock. The purchase price of each Pre-Funded Warrant was $0.99,
and the exercise price of each Pre-Funded Warrant is $0.01 per share. The Pre-Funded Warrants are immediately exercisable and may be
exercised at any time until all of the Pre-Funded Warrants are exercised in full.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares, the Pre-Funded Warrants and the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (the &#8220;Pre-Funded
Warrant Shares&#8221;) were offered by us pursuant to an effective shelf registration statement on Form S-3 (No. 333-258386), which was
declared effective by the SEC on August 9, 2021, and a corresponding prospectus supplement, dated November 28,2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a concurrent private placement, we sold to the Selling Stockholder warrants (the &#8220;Purchase Warrants&#8221; and together with the
Pre-Funded Warrants, the &#8220;Warrants&#8221;) to purchase up to 3,675,000 shares of Common Stock (the &#8220;Purchase Warrant Shares&#8221;
and together with the Pre-Funded Warrant Shares, the &#8220;Warrant Shares&#8221;). The Purchase Warrants will be exercisable beginning
six months and one day from the date of the Purchase Agreement (the &#8220;Initial Exercise Date&#8221;) at an exercise price of $1.36
per share and will expire on the five-year anniversary of the Initial Exercise Date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Warrants will be exercisable on a &#8220;cashless&#8221; basis if at any time they are exercised there is not an effective registration
statement for the resale of the Purchase Warrant Shares in place, or there is not a current resale prospectus then available.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price and number of Warrant Shares will be subject to adjustment in the event of any stock dividend or split, reverse stock
split, recapitalization, reorganization or similar transaction, as described in the Warrants.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contained customary representations and warranties and agreements of the Company and the Selling Stockholder and customary
indemnification rights and obligations of the parties. The closing of the offering occurred on November 30, 2022 (the &#8220;Closing
Date&#8221;), once the customary closing conditions were met. We received gross proceeds of approximately $2.45 million in connection
with the offering, before deducting placement agent fees and related offering expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date of the Purchase Agreement until six months after the Closing Date, the Selling Stockholder has a right to participate in subsequent
financings by us up to an amount equal to 30% of the total amount of such financing by giving notice of the exercise of such right on
the third trading day after which the Selling Stockholder receives notice of the proposed financing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date of the Purchase Agreement until 90 days after the Closing Date, the provisions of the Purchase Agreement generally prohibit
us from issuing or agreeing to issue shares of Common Stock or Common Stock equivalents other than under equity compensation plans, outstanding
rights to acquire Common Stock or Common Stock equivalents, or in connection with certain strategic transactions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the terms of the
Purchase Agreement, we are also prohibited from (i) entering into an &#8220;ATM&#8221; offering, that is an offering of Common Stock into
the existing trading market for our Common Stock at a price or prices related to the then-market price of the Common Stock, within six
months after the date of the Purchase Agreement and (ii) issuing or agreeing to issue shares of Common Stock or Common Stock equivalents
that are variable until the earlier of 12 months after the date of the Purchase Agreement or the date the Purchaser no longer holds any
Warrants.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Warrants and the Purchase Warrant Shares were not registered under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), instead were offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated
thereunder, or in the event of an issuance of Warrant Shares on a cashless basis, pursuant to the exemption provided in Section 3(a)(9)
under the Securities Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Purchase Agreement, we entered into a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;)
with the Selling Stockholder. Under the Registration Rights Agreement, the Company was required to file a registration statement within
15 calendar days after signing the Registration Rights Agreement to register the Purchase Warrant Shares for resale by the Selling Stockholder.
The Company&#8217;s failure to meet the filing deadlines and other requirements set forth in the Registration Rights Agreement may subject
the Company to monetary penalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Benchmark Company, LLC acted as the sole placement agent (the &#8220;Placement Agent&#8221;) on a &#8220;best efforts&#8221; and exclusive
basis, in connection with the offering. The Placement Agent was entitled to a cash fee of 7.0% of the gross proceeds paid to the Company
for the Shares and the Warrants and reimbursement of certain out-of-pocket expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the Pre-Funded Warrants, the Purchase Warrants, the Purchase Agreement and the Registration Rights Agreement do
not purport to be complete and are qualified in their entirety by reference to the definitive transaction documents. Copies of the form
of Purchase Agreement, the Registration Rights Agreement, the form of Pre-Funded Warrant and the form of Purchase Warrant were attached
as Exhibits 10.1, 10.2, 4.1 and 4.2, respectively, to our Current Report on Form 8-K filed with the SEC on November 30, 2022, which is
incorporated by reference herein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF PROCEEDS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any proceeds from the sale of the shares of common stock by the Selling Stockholder. All net proceeds from the sale
of the shares of Common Stock covered by this prospectus will go to the Selling Stockholder. We expect that the Selling Stockholder will
sell their shares of Common Stock as described under &#8220;Plan of Distribution.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><div><a id="p_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIVIDEND
POLICY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have paid no cash dividends on our shares of Common Stock and we do not expect to pay cash dividends on our Common Stock in
the foreseeable future. We intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any
potential return investors may have in our Common Stock will be in the form of appreciation, if any, in the market value of their shares
of Common Stock. We are not subject to any legal restrictions respecting the payment of dividends, except that we may not pay dividends
if the payment would render us insolvent. Any future determination as to the payment of cash dividends on our Common Stock will be at
the discretion of our Board of Directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DESCRIPTION
OF CAPITAL STOCK</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital
Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of our capital stock is summarized from, and qualified in its entirety by reference to, our certificate of incorporation,
as amended, including the certificates of designation, as amended, setting forth the terms of our preferred stock. This summary is not
intended to give full effect to provisions of statutory or common law. We urge you to review the following documents because they, and
not this summary, define the rights of a holder of shares of common stock and preferred stock:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
General Corporation Law of the State of Delaware, or the &#8220;DGCL&#8221;, as it may be amended from time to time;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            certificate of incorporation, as it may be amended or restated from time to time; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            bylaws, as they may be amended or restated from time to time.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this prospectus,
our authorized capital stock currently consists of 140,000,000 shares, which are divided into two classes consisting of 120,000,000 shares
of Common Stock, par value $0.001 per share, and 20,000,000 shares of preferred stock, par value $0.01 per share.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 9, 2022, there
were 14,073,912 shares of Common Stock outstanding and 1 share of Series A special voting preferred stock outstanding. As of December
9, 2022, there were outstanding 9,106,876 exchangeable shares exchangeable for 9,106,876 shares of Common Stock, 1,504,678 shares of Common
Stock issuable upon the exercise of outstanding stock options, 1,370,088 shares of Common Stock issuable upon the vesting of outstanding
restricted stock units, 1,438,946 shares of Common Stock available for future issuance under the Amended and Restated 2019 Stock Incentive
Plan, warrants to purchase up to 33,125 shares of Common Stock with an exercise price of $47.00 per share, warrants to purchase up to
100,771 shares of Common Stock with an exercise price of $2.40 per share, Pre-Funded Warrants to purchase up to 1,150,000 shares of Common
Stock with an exercise price of $0.01 per share and Purchase Warrants to purchase up to 3,675,000 shares of Common Stock with an exercise
price of $1.36 per share.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 9, 2022, there were 14,073,912 shares of Common Stock outstanding and held of record by 49 stockholders. The actual number of
stockholders is significantly greater than this number of record stockholders and includes stockholders who are beneficial owners but
whose shares are held in street name by brokers and other nominees. This number of stockholders of record also does not include stockholders
whose shares may be held in trust by other entities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
holder of our Common Stock is entitled to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="padding-right: 0; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0"></td><td style="padding-right: 0; font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            vote per share on all matters submitted to a vote of the stockholders;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="padding-right: 0; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0"></td><td style="padding-right: 0; font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dividends
                                            as may be declared by our board of directors out of funds legally available for that purpose,
                                            subject to the rights of any preferred stock that may be outstanding; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="padding-right: 0; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0"></td><td style="padding-right: 0; font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-left: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">his,
                                            her or its pro rata share in any distribution of our assets after payment or providing for
                                            the payment of liabilities and the liquidation preference of any outstanding preferred stock
                                            in the event of liquidation.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock have no cumulative voting rights, redemption rights or preemptive rights to purchase or subscribe for any shares of our
Common Stock or other securities. All of the outstanding shares of Common Stock are fully paid and nonassessable. The rights, preferences
and privileges of holders of our Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of
any series of preferred stock that we may designate and issue in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has the authority, subject to any limitations prescribed by Delaware law, to issue shares of preferred stock in one
or more series and to fix and determine the relative rights and preferences of the shares constituting any series to be established,
without any further vote or action by the stockholders. Any shares of our preferred stock so issued may have priority over our Common
Stock with respect to dividend, liquidation and other rights.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of our preferred stock with voting or conversion rights that could adversely affect the
voting power or other rights of the holders of our Common Stock. Although the issuance of our preferred stock could provide us with flexibility
in connection with possible acquisitions and other corporate purposes, under some circumstances, it could have the effect of delaying,
deferring or preventing a change of control.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series
A Special Voting Preferred Stock</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;15, 2021, we filed the Certificate of Designation of Series A Special Voting Preferred Stock (the &#8220;Certificate of
Designation&#8221;) with the Secretary of State of the State of Delaware to designate Series A Special Voting Preferred Stock (the &#8220;Special
Voting Share&#8221;) in accordance with the terms of the Arrangement Agreement in order to enable the holders of exchangeable shares
to have their voting rights exercised. After the closing of the Arrangement, each exchangeable share has become exchangeable for one
share of Common Stock of the Company and while outstanding, the Special Voting Share enables holders of exchangeable shares to cast votes
on matters for which holders of the Common Stock are entitled to vote, and by virtue of the share terms relating to the exchangeable
shares, to receive dividends that are economically equivalent to any dividends declared with respect to the shares of Common Stock. The
foregoing is only a brief description of the material terms of the Certificate of Designation and does not purport to be a complete description
of the rights and obligations thereunder. Such description is qualified in its entirety by reference to the Certificate of Designation,
which is attached to the Current Report on Form&#160;8-K filed with the SEC on December 20, 2021. As of December 9, 2022, there was one
Special Voting Share authorized and outstanding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Antitakeover
Effects of Provisions of Our Certificate of Incorporation and Bylaws and of Delaware Law</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of our charter documents and Delaware law could have an anti-takeover effect and could delay, discourage or prevent a tender
offer or takeover attempt that a stockholder might consider to be in its best interests, including attempts that might otherwise result
in a premium being paid over the market price of our Common Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Bylaws</i></b>.
Our bylaws provide that special meetings of stockholders may be called only by our chairman of the board, our chief executive officer,
a majority of the total number of authorized directors or any individual holder of 25% of the outstanding shares of Common Stock. These
provisions could delay consideration of a stockholder proposal until the next annual meeting. Our bylaws provide for an advance notice
procedure for the nomination, other than by or at the direction of our board of directors, of candidates for election as directors, as
well as for other stockholder proposals to be considered at annual meetings of stockholders. In addition, under our bylaws newly created
directorships resulting from any increase in the number of directors or any vacancies in the board resulting from death, resignation,
retirement, disqualification, removal from office or other cause during a director&#8217;s term in office can be filled by the vote of
the remaining directors in office, and the board is expressly authorized to amend the bylaws without stockholder consent. Accordingly,
these provisions could discourage a third party from initiating a proxy contest, making a tender offer or otherwise attempting to gain
control of our company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Delaware
Anti-Takeover Statute</i></b>. Section 203 of the Delaware General Corporation Law, or DGCL, generally prohibits a publicly-held Delaware
corporation from engaging in an acquisition, asset sale or other transaction resulting in a financial benefit to any person who, together
with affiliates and associates, owns, or within three years did own, 15.0% or more of a corporation&#8217;s voting stock. The prohibition
continues for a period of three years after the date of the transaction in which the person becomes an owner of 15.0% or more of the
corporation&#8217;s voting stock, unless the business combination is approved in a prescribed manner. The statute could prohibit, delay,
defer or prevent a change in control with respect to our company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary is qualified in its entirety by reference to the complete text of any statutes referred to below and to the Restated
Certificate of Incorporation and the Amended and Restated Bylaws of Peraso Inc., a Delaware corporation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation, or
a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in
related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party
to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and
in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding,
had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation,
no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable
to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the
adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity
for such expenses which the Court of Chancery or such other court shall deem proper.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation states that, to the fullest extent permitted by the DGCL as it may be amended, none of our directors shall
be personally liable to us or to our stockholders for monetary damages for breach of fiduciary duty as a director. The Certificate of
Incorporation also states that we shall, to the fullest extent permitted by Section 145 of the DGCL, indemnify and hold harmless all
of our directors. To the extent permitted by applicable law, we are also authorized to provide indemnification of (and advancement of
expenses to) agents (and any other persons to which Delaware law permits us to provide indemnification) through bylaw provisions, agreements
with such agents or other persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification and
advancement otherwise permitted by Section 145 of the DGCL, subject only to limits created by applicable Delaware law (statutory or non-statutory)
with respect to actions for breach of duty to us, our stockholders, and others.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted by our Certificate of Incorporation and the DGCL, our Bylaws provide that we shall indemnify our directors and officers against
actions by third parties, and that we shall indemnify our directors, officers and employees against actions brought by or on behalf of
the Company. The Bylaws also permit us to secure insurance on behalf of any officer, director, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise against any liability arising out of his or her actions in that capacity if he
or she is serving at our request. We have obtained officer and director liability insurance with respect to liabilities arising out of
various matters, including matters arising under the&#160;Securities Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into agreements with each of our directors that, among other things, indemnify them for certain expenses (including attorneys&#8217;
fees), judgments, fines and settlement amounts incurred by them in any action or proceeding, including any action by us or in our right,
arising out of the person&#8217;s services as a director or officer of ours or any other company or enterprise to which the person provides
services at our request.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of business, we enter into contractual arrangements under which we may agree to indemnify the counter-party from
losses relating to a breach of representations and warranties, a failure to perform certain covenants, or claims and losses arising from
certain external events as outlined within the contract, which may include, for example, losses arising from litigation or claims relating
to past performance. Such indemnification clauses may not be subject to maximum loss clauses. We have also entered into indemnification
agreements with our officers and directors. No material amounts related to these indemnifications are reflected in our consolidated financial
statements for the years ended December 31, 2021 or 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not estimated the maximum potential amount of indemnification liability under these agreements due to the limited history
of prior claims and the unique facts and circumstances applicable to each particular agreement. To date, the Company has not made any
payments related to these indemnification agreements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING
STOCKHOLDER</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 3,675,000 shares of Common stock being registered for resale hereby are issuable upon exercise of the Purchase Warrants that were
issued to Armistice Capital Master Fund Ltd, also referred to herein as the Selling Stockholder. For additional information regarding the issuance of those Purchase
Warrants, see &#8220;Private Offering of Purchase Warrants&#8221; above. We are registering the shares of Common Stock issuable upon exercise
of the Purchase Warrants in order to permit the Selling Stockholder to offer the shares for resale from time to time. The Selling Stockholder
has not had any material relationship with us within the past three years.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the Selling Stockholder and other information regarding the beneficial ownership of the shares of Common Stock by such
Selling Stockholder. The second column lists the number of shares of Common Stock beneficially owned by the Selling Stockholder, based
on its ownership of the Purchase Warrants, as of December 9, 2022, assuming exercise of the Purchase Warrants held by such Selling Stockholder
on that date, without regard to any limitations on exercises. The third column lists the shares of Common Stock being offered by this
prospectus by the Selling Stockholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the Selling Stockholder this prospectus generally covers the resale
of the maximum number of shares of Common Stock issuable upon exercise of the Purchase Warrants, determined as if the outstanding Purchase
Warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed
with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as
provided in the registration right agreement, without regard to any limitations on the exercise of the Purchase Warrants. The fourth
column assumes the sale of all of the shares offered by each Selling Stockholder pursuant to this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Purchase Warrants, the Selling Stockholder may not exercise the Purchase Warrants to the extent such exercise would
cause the Selling Stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of Common
Stock which would exceed 4.99% of our then outstanding Common Stock following such exercise, excluding for purposes of such determination
shares of Common Stock issuable upon exercise of such Purchase Warrants which have not been exercised. The number of shares in the second
and fourth columns do not reflect this limitation. The Selling Stockholder may sell all, some or none of their shares in this offering.
See &#8220;Plan of Distribution.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Selling
                                                                     Stockholder</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
of Shares of Common Stock Owned Prior to Offering</b>&#160;</span></p></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximum
Number of Shares of Common Stock to be Sold Pursuant to this Prospectus</b>&#160;</span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
of Shares of Common Stock Owned After the Offering</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Armistice Capital Master Fund Ltd. (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">2,310,000</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,675,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">2,310,000</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            shares are directly held by Armistice and may be deemed to be indirectly beneficially owned
                                            by: (i) Armistice Capital, LLC (&#8220;Armistice Capital&#8221;), as the investment manager
                                            of Armistice and (ii) Steven Boyd, as the Managing Member of Armistice Capital. Armistice
                                            Capital and Steven Boyd disclaim beneficial ownership of the securities except to the extent
                                            of their respective pecuniary interests therein.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares beneficially owned includes (i) 1,150,000 shares of Common Stock and issuable upon the exercise of the Pre-Funded
    Warrants and (ii) 3,675,000 shares of Common Stock issuable upon the exercise of the Purchase Warrants, which will be exercisable beginning six months and one day from the
date of the Purchase Agreement. Armistice is prohibited from exercising any portion of a warrant and that would result in Armistice
    owning a percentage of our outstanding Common Stock exceeding the ownership limitations contained within each instrument (9.99% and
    4.99%, respectively) after giving effect to the issuance of Common Stock in connection with Armistice&#8217;s exercise. The shares
    owned before and after this offering assumes the exercise of all warrants held by Armistice, notwithstanding the existence of the
    beneficial ownership limitations described above. The address of Armistice Capital Master Fund Ltd. is c/o Armistice Capital, LLC,
    510 Madison Avenue, 7th Floor, New York, NY 10022.&#160;</span></p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLAN
OF DISTRIBUTION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholder and any of its respective pledgees, assignees and successors-in-interest may, from time to time, sell any or all
of their securities covered hereby on the Nasdaq or any other stock exchange, market or trading facility on which the securities are
traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholder may use any one or more
of the following methods when selling securities:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
                                            trades in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
                                            negotiated transactions;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
                                            of short sales;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            transactions through broker-dealers that agree with such Selling Stockholder to sell a specified
                                            number of such securities at a stipulated price per security;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 38.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            combination of any such methods of sale; or</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other method permitted pursuant to applicable law.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholder may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available,
rather than under this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholder may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholder may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholder may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholder and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. The Selling Stockholder has informed us that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to pay certain fees and expenses incurred by us incident to the registration of the securities. We have agreed to indemnify
each Selling Stockholder against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by a Selling Stockholder
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
us to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect
or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar
effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state
securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholder will be subject to applicable provisions of the Exchange
Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common
stock by the Selling Stockholder or any other person. We will make copies of this prospectus available to the Selling Stockholder and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Company
Standstill</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
the date of the Purchase Agreement until 90 days after the Closing Date, the provisions of the Purchase Agreement generally prohibit
us from issuing or agreeing to issue shares of Common Stock or common stock equivalents other than under equity compensation plans, outstanding
rights to acquire Common Stock or common stock equivalent, or in connection with certain strategic transactions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Purchase Agreement, we are also prohibited from (i) entering into an at-the-market, or ATM, offering, that is an
offering of Common Stock into its existing trading market for the Common Stock at a price or prices related to the then-market price
of the Common Stock, within six months after the date of the Purchase Agreement and (ii) issuing or agreeing to issue shares of Common
Stock or common stock equivalents that are variable until the earlier of 12 months after the date of the Purchase Agreement or the date
the investor no longer holds any Pre-Funded Warrants or Purchase Warrants.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the shares of Common Stock offered hereby will be passed upon for us by Mitchell Silberberg &amp; Knupp LLP.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPERTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our consolidated financial
statements as of and for the years ended December 31, 2021 and 2020 incorporated in this Registration Statement on Form S-1 by reference
to the&#160;Annual Report on Form 10-K for the year ended December 31, 2021, have been so incorporated in reliance on the report of Weinberg
&amp; Company, P.A., an independent registered public accounting firm, as indicated in their report with respect thereto, and are included
herein in reliance upon the authority of said firm as experts in auditing and accounting in giving said report.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC, under the Securities Act, a registration statement on Form S-1 relating to the securities offered hereby. This
prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedules thereto. For
further information with respect to our company and the securities we are offering by this prospectus you should refer to the registration
statement, including the exhibits and schedules thereto. The SEC also maintains an Internet site that contains reports, proxy and information
statements and other information regarding registrants that file electronically with the SEC. The SEC&#8217;s website address is http://www.sec.gov.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file periodic reports, proxy statements and other information with the SEC in accordance with requirements of the Exchange Act. These
periodic reports, proxy statements and other information are available at the SEC&#8217;s website address referred to above. You may
also access our reports and proxy statements free of charge at our website, www.peraso.com. The information contained on our website
is not a prospectus and does not constitute a part of this prospectus. The prospectus included in this filing is part of a registration
statement filed by us with the SEC. The full registration statement can be obtained from the SEC, as indicated above, or from us. You
may request a copy of any of our periodic reports filed with the SEC at no cost, by writing or telephoning us at the following address:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peraso
Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2309
Bering Dr.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Jose, California 95131</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(408) 418-7500</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
James  Sullivan, Chief Financial Officer</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in or incorporated by reference or provided in this prospectus. We have not authorized
anyone else to provide you with different information. We are not making an offer of these securities in any state where the offer is
not permitted. You should not assume the information in this prospectus is accurate as of any date other than the date on the front of
this prospectus.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="p_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCORPORATION
OF CERTAIN DOCUMENTS BY REFERENCE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to incorporate by reference the information we file with it, which means that we can disclose important information to
you by referring you to another document that we have filed separately with the SEC. We hereby incorporate by reference the following
information or documents into this prospectus, except for information &#8220;furnished&#8221; under Item 2.02 or Item 7.01 of Form 8-K
or other information &#8220;furnished&#8221; to the SEC which is not deemed filed and not incorporated in this prospectus:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
Annual Report on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022012981/prso-10k_20211231.htm">Form 10-K</a> for the year ended December 31, 2021, filed with the SEC on March 31, 2022;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
Definitive Proxy Statement on <a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022038476/prso-def14a_20221222.htm">Schedule 14A</a> relating to our 2022 Annual Meeting of Stockholders, filed with the SEC on November 30, 2022;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
Quarterly Reports on Form 10-Q for the quarterly periods ended <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022020074/prso-10q_20220331.htm">March 31, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022029517/prso-10q_20220630.htm">June 30, 2022</a>, and <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022037677/prso-10q_20220930.htm">September 30, 2022</a> filed with the SEC
on May 13, 2022 August 15, 2022, and November 14, 2022, respectively;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
Current Reports on Form 8-K filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022007226/mosy-8k_20220218.htm">February 25, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000165495422002720/pera_8k.htm">March 8, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022009683/mosy-8k_20220308.htm">March 10, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022016846/prso-8k_20220425.htm">April 29, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000165495422006301/prso_8k.htm">May 9, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022028489/prso-8k_20220805.htm">August 8, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000165495422011402/prso_8k.htm">August 15, 2022</a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000165495422015319/prso_8k.htm">November 15, 2022</a> and <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/890394/000156459022038601/prso-8k_20221128.htm">November 30, 2022</a>; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
description of our Common Stock contained in the &#8220;Description of Securities&#8221; filed as <a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022012981/prso-ex46_449.htm">Exhibit 4.6</a> to our Annual Report on
Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information
in this prospectus or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces
such information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also incorporate by reference any future filings (other than current
reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) made with the
SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering of the securities made
by this prospectus. Information in such future filings updates and supplements the information provided in this prospectus. Any statements
in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with
the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document
modify or replace such earlier statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
written or oral request, we will provide to you, without charge, a copy of any or all of the documents that are incorporated by reference
into this prospectus but not delivered with the prospectus, including exhibits which are specifically incorporated by reference into
such documents. Requests should be directed to: Peraso Inc., Attention: James  Sullivan, Chief Financial Officer, 2309 Bering Dr.,
San Jose, California 95131, Tel: (408) 418-7500.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 24; Options: NewSection; Value: 20 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<img alt="" src="image_001.jpg"/></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>3,675,000 Shares of Common Stock issuable upon
exercise of the Purchase Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>_____________, 2022</b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
13. Other Expenses of Issuance and Distribution.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the fees and expenses payable in connection with the registration of the securities hereunder. All amounts
are estimates except the SEC registration fee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount <br/> to be paid</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">SEC registration fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">550.77</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Legal fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounting fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Miscellaneous fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,000.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,550.77</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. Indemnification of Directors and Officers.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary is qualified in its entirety by reference to the complete text of any statutes referred to below and to the Restated
Certificate of Incorporation and the Amended and Restated Bylaws of Peraso Inc., a Delaware corporation (the &#8220;Company&#8221;).</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation, or
a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in
related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party
to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and
in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding,
had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation,
no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable
to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the
adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity
for such expenses which the Court of Chancery or such other court shall deem proper.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Certificate of Incorporation states that, to the fullest extent permitted by the DGCL as it may be amended, none of its
directors shall be personally liable to the Company or to its stockholders for monetary damages for breach of fiduciary duty as a director.
The Certificate of Incorporation also states that the Company shall, to the fullest extent permitted by Section 145 of the DGCL, indemnify
and hold harmless all of its directors. To the extent permitted by applicable law, the Company is also authorized to provide indemnification
of (and advancement of expenses to) agents (and any other persons to which Delaware law permits the Company to provide indemnification)
through bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise,
in excess of the indemnification and advancement otherwise permitted by Section 145 of the DGCL, subject only to limits created by applicable
Delaware law (statutory or non-statutory) with respect to actions for breach of duty to the Company, its stockholders, and others.</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted by the Company&#8217;s Certificate of Incorporation and the DGCL, the Company&#8217;s Bylaws provide that the Company shall
indemnify its directors and officers against actions by third parties, and that the Company shall indemnify its directors, officers and
employees against actions brought by or on behalf of the Company. The Bylaws also permit the Company to secure insurance on behalf of
any officer, director, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability
arising out of his or her actions in that capacity if he or she is serving at the Company&#8217;s request. The Company has obtained officer
and director liability insurance with respect to liabilities arising out of various matters, including matters arising under the Securities
Act.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into agreements with each of its directors and executive officers that, among other things, indemnify them for certain
expenses (including attorneys&#8217; fees), judgments, fines and settlement amounts incurred by them in any action or proceeding, including
any action by the Company or in the Company&#8217;s right, arising out of the person&#8217;s services as a director or officer of the
Company or any other company or enterprise to which the person provides services at the Company&#8217;s request.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 26; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. Recent Sales of Unregistered Securities.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information regarding shares of capital stock issued by the Company since January 1, 2019 that were not registered under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Also included is the consideration received by the Company
for such shares and information relating to the section of the Securities Act, or rule of the SEC, under which exemption from registration
was claimed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            February 1, 2021, the Company issued 42,672 shares of Common Stock valued at $139,964 to
                                            the holder of the Senior Secured Convertible Notes due August 15, 2023 in settlement of the
                                            accrued interest for the six month period ended February 15, 2021. Such shares were issued
                                            in a private placement transaction that was exempt from the registration requirements under
                                            the Securities Act pursuant to Section 4(a)(2) of the Securities Act.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            December 17, 2021 (the &#8220;Closing Date&#8221;), pursuant to the terms and conditions
                                            of that certain Arrangement Agreement, dated September 14, 2021, as amended (the &#8220;Arrangement
                                            Agreement&#8221;), an aggregate of 9,295,097 exchangeable shares and 3,558,151 shares of
                                            Common Stock were issued to the former stockholders of Peraso Technologies Inc. (&#8220;Peraso&#8221;).
                                            Of such shares, pursuant to the terms of the Arrangement Agreement, the Company held in escrow
                                            an aggregate of 1,312,878 exchangeable shares and 502,567 shares of Common Stock (collectively,
                                            the &#8220;Earnout Shares&#8221;). The Earnout Shares are escrowed pursuant to the terms
                                            of an escrow agreement on a pro rata basis from the aggregate consideration received by the
                                            Peraso stockholders, subject to the offset by the Company for any losses in accordance with
                                            the Arrangement Agreement. Such Earnout Shares shall be released, subject to any offset claim,
                                            upon the satisfaction of the earlier of: (a)&#160;any date following the first anniversary
                                            of the Closing Date and prior to the third anniversary of the Closing Date where the volume
                                            weighted average price of the Common Stock for any 20 trading days within a period of 30
                                            consecutive trading days is at least $8.57 per share, subject to adjustment for stock splits
                                            or other similar transactions; (b)&#160;the date of any sale of all or substantially all
                                            of the assets or shares of the Company; or (c)&#160;the date of any bankruptcy, insolvency,
                                            restructuring, receivership, administration,&#160;wind-up,&#160;liquidation, dissolution,
                                            or similar event involving the Company. All and any voting rights and other stockholder rights,
                                            other than with respect to dividends and distributions, with respect to the Earnout Shares
                                            are suspended until the Earnout Shares are released from escrow.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of (i)&#160;the shares of Common Stock to those Peraso stockholders that elected to receive or otherwise will receive shares
of Common Stock in connection with the Arrangement Agreement and (ii)&#160;the exchangeable shares to those Peraso stockholders that
elected to receive exchangeable shares in connection with the Arrangement Agreement were issued in reliance upon the exemption from registration
provided by Section&#160;3(a)(10) of the Securities Act pursuant to the approval of the terms and conditions of the issuance and exchange
of such securities by the Ontario Superior Court of Justice (Commercial List) by the final order issued and entered on November&#160;26,
2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            November 28, 2022<i>,</i> the Company entered into a Securities Purchase Agreement (the &#8220;Purchase
                                            Agreement&#8221;) with Armistice Capital Master Fund Ltd. (the &#8220;Purchaser&#8221;),
                                            pursuant to which the Company agreed to offer and sell to the Purchaser, in a registered
                                            direct offering, an aggregate of 1,300,000 shares (the &#8220;Shares&#8221;) of common stock,
                                            par value $0.001 per share (the &#8220;Common Stock&#8221;), at a negotiated purchase price
                                            of $1.00 per share. The Company also offered and sold to the Purchaser pre-funded warrants
                                            to purchase up to 1,150,000 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221;),
                                            in lieu of shares of Common Stock at the Purchaser&#8217;s election. Each Pre-Funded Warrant
                                            is exercisable for one share of Common Stock. The purchase price of each Pre-Funded Warrant
                                            was $0.99, and the exercise price of each Pre-Funded Warrant is $0.01 per share. The Pre-Funded
                                            Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded
                                            Warrants are exercised in full.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares, the Pre-Funded Warrants and the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (the &#8220;Pre-Funded
Warrant Shares&#8221;) were offered by the Company pursuant to an effective shelf registration statement on Form S-3 (No. 333-258386),
which was declared effective by the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 9, 2021 (the &#8220;Registration
Statement&#8221;) and a corresponding prospectus supplement, dated November 28,2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a concurrent private placement offering, the Company also issued to the Purchaser warrants (the &#8220;Purchase Warrants&#8221; and together
with the Pre-Funded Warrants, the &#8220;Warrants&#8221;) to purchase up to 3,675,000 shares of Common Stock (the &#8220;Purchase Warrant
Shares&#8221; and together with the Pre-Funded Warrant Shares, the &#8220;Warrant Shares&#8221;). The Purchase Warrants will be exercisable
beginning six months and one day from the date of the Purchase Agreement (the &#8220;Initial Exercise Date&#8221;) at an exercise price
of $1.36 per share and will expire on the five-year anniversary of the Initial Exercise Date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the offering occurred on November 30, 2022. The Company received gross proceeds of approximately $2.45 million in connection
with the offering, before deducting placement agent fees and related offering expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Warrants and the Purchase Warrant Shares were not registered under the Securities Act pursuant to the exemption provided in
Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, or in the event of an issuance of Warrant Shares on a
cashless basis, pursuant to the exemption provided in Section 3(a)(9) under the Securites Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16. Exhibits and Financial Statement Schedules.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
<i>Exhibit Index</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1(1)**</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459021047983/mosy-ex21_34.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arrangement Agreement with Peraso Technologies Inc.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2(2)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459021051571/mosy-ex21_6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amending Agreement dated October 21, 2021</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(3)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465910058160/a10-20986_1ex3d6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated Certificate of Incorporation of the Company</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1(4)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000155837017000604/mosy-20170214ex319e9145f.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Restated Certificate of Incorporation of the Company</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2(5)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312519230974/d774798dex31.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Peraso Inc., filed with the Secretary of State of the State of Delaware on August 27, 2019</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.3(6)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312521362129/d276231dex31.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Articles of Incorporation (Name Change)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.4(7)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312521362129/d276231dex32.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Designation of Series A Special Voting Preferred Stock</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2(8)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459021058101/mosy-ex31_20.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of the Company</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1(9)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000091205700041425/a2025213zex-4_1.txt">Specimen Common Stock Certificate</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2(10)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465917042948/a17-15893_3ex4d1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Stock Purchase Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3(11)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465917042948/a17-15893_3ex10d1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5(12)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459018023866/mosy-ex46_10.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Stock Purchase Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6(13)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022012981/prso-ex46_449.htm">Description of Securities</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7.1(14)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312519230974/d774798dex31.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peraso Inc. 2010 Amended and Restated Equity Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7.2(15)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022000694/mosy-ex42_136.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Peraso Inc. 2019 Stock Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.1(16)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465910040205/a10-14520_8ex4d10.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Agreement for Stock Option Grant pursuant to the Peraso Inc. Amended and Restated 2010 Equity Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.2(17)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459019043184/mosy-ex410_9.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Notice of Grant of Stock Option Award and Agreement pursuant to the Peraso Inc. 2019 Stock Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.1(18)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465913061552/a13-13816_1ex10d23.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Notice of Grant of Restricted Stock Unit Award and Agreement under the Peraso Inc. Amended and Restated 2010 Equity Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.2(19)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459019043184/mosy-ex410_9.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Notice of Grant of Restricted Stock Unit Award and Agreement under the Peraso Inc. 2019 Stock Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10(20)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022000694/mosy-ex45_95.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Peraso Technologies Inc. 2009 Share Option Plan</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11(21)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022038601/prso-ex41_6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Common Stock Purchase Warrant</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12(22)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022038601/prso-ex42_7.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Stock Purchase Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1+</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea170067ex5-1_perasoinc.htm">Opinion of Mitchell Silberberg &amp; Knupp LLP</a></span></td></tr>

<tr style="vertical-align: top; ">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1(23)*</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000104746908002918/a2183589zex-10_26.htm">Employment offer letter agreement between the Company and James Sullivan dated December 21, 2007</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(24)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000104746908002918/a2183589zex-10_27.htm">Change-in-control Agreement between the Company and James Sullivan dated January 18, 2008</a></span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3(25)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465910040205/a10-14520_8ex4d10.htm">Form of Option Agreement for Stock Option Grant pursuant to 2010 Equity Incentive Plan</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4(26)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465909036726/a09-14615_1ex4d8.htm">Form of Notice of Restricted Stock Unit Award and Agreement under the Peraso Inc. 2010 Amended and Restated Equity Incentive Plan</a></span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5(27)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000104746912002721/a2207956zex-10_19.htm">Form of New Employee Inducement Grant Stock Option Agreement (revised February 2012)&#160;</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6(28)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465912056381/a12-13852_1ex10d22.htm">Form of Indemnification Agreement used from June 2012 to present</a></span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7(29)</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000164538317000030/mosy-20170930xex99b.htm">Sublease Agreement with Cyren, Inc. dated October 3, 2017</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8(30)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000110465916134319/a16-14831_2ex99dd7.htm">Executive Change-in-Control and Severance Policy</a></span></td></tr>
<tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9(31)*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312518274625/d579907dex1028.htm">Employment offer letter agreement between the Company and Daniel Lewis dated August 8, 2018</a></span></td></tr>
</table><div>
</div><p style="margin: 0">&#160;&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10(32)</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459018023866/mosy-ex1026_8.htm">Securities Purchase Agreement</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11(33)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312520110749/d918418dex101.htm">Securities Purchase Agreement</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12(34)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459021014203/mosy-ex1021_330.htm">Sublease Addendum #2 to the Lease between Cyren Ltd. and Peraso Inc., dated September 30, 2020, by and between Peraso Inc., and Cyren Ltd</a>.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13(35)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312521362129/d276231dex101.htm">Form of Lock-Up Agreement</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14(36)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312521362129/d276231dex102.htm">Intercompany Services Agreement</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15(37)*</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000119312521362129/d276231dex103.htm">Employment Agreement (Ronald Glibbery)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16(38)*</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022029517/prso-ex101_146.htm">Amendment to offer of employment between the Company and Daniel Lewis dated April 25, 2022</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17(39)*</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022029517/prso-ex102_147.htm">Amendment to offer of employment between the Company and James Sullivan dated April 25, 2022</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18(40)*</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022029517/prso-ex103_148.htm">Amendment to employment agreement between Peraso Technologies Inc. and Brad Lynch dated April 25, 2022</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19(41)**</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022037677/prso-ex101_158.htm">Technology License and Patent Assignment Agreement By and Between Intel Corporation and Peraso Inc. dated August 5, 2022</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20(42)**</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022038601/prso-ex101_9.htm">Form of Securities Purchase Agreement</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21(43)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022038601/prso-ex102_10.htm">Form of Registration Rights Agreement</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1(44)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/890394/000156459022012981/prso-ex211_8.htm">List of Subsidiaries</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1+</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea170067ex23-1_perasoinc.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Independent Registered Public Accounting Firm-Weinberg &amp; Co., P.A.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2+</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea170067ex5-1_perasoinc.htm">Consent of Mitchell Silberberg &amp; Knupp LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1+</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#poa_001">Power of Attorney (see signature page)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104+</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107+</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea170067ex-fee_perasoinc.htm">Filing fee table</a>&#160;</span></td></tr>
  </table><div>
</div><p style="margin: 0"></p><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to the same-numbered exhibit to Form 8-K, filed by the Company on September 15, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 2.1 to Form 8-K, filed by the Company on October 22, 2021 (Commission File No. 000-32929)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.6 to Form 8-K filed by the Company on November 12, 2010 (Commission File No. 000-32929)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Company on February 14, 2017 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Company on August 27, 2019 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Company on December 20, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.2 to Form 8-K filed by the Company on December 20, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Company on November 23, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference
to Exhibit 4.1 to Form 10-K filed by the Company on March 31, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.1 to Form 8-K filed by the Company on June 30, 2017 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Company on June 30, 2017 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.6 to Form 8-K filed by the Company on October 3, 2018 (Commission File No. 000-32929).</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.6 to Form 10-K filed by the Company on March 31, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 3.1 to Form 8-K filed by the Company on August 27, 2019 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.2 to Form S-8 filed by the Company on January 7, 2022 (Commission File No. 333-262062).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.10 to the Company&#8217;s Registration Statement on Form S-8, filed July 28, 2010 (Commission File No. 333-168358).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.10 to the Company&#8217;s Current Report on Form S-8, filed on November 13, 2019 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.23 to the Company&#8217;s Form 10-Q filed on August 8, 2013 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.10 to the Company&#8217;s Current Report on Form S-8, filed November 13, 2019 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.5 to the registration statement on Form S-8 filed by the Company on January 7, 2022 (Commission File No. 333-262062).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.1 to Form 8-K filed by the Company on November 30, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.2 to Form 8-K filed by the Company on November 30, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.26 to Form 10-K filed by the Company on March 17, 2008 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.27 to Form 10-K filed by the Company on March 17, 2008 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.10 to Form S-8 filed by the Company on July 28, 2010 (Commission File No. 333-168358).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 4.8 to Form S-8 filed by the Company on June 5, 2009 (Commission File No. 333-159753).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.19 to Form 10-K filed by the Company on March 15, 2012 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.22 to Form 10-Q filed by the Company on August 9, 2012 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 99.2 to Form 10-Q filed by the Company on November 14, 2017 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 99 to Schedule TO filed by the Company on July 26, 2016 (Commission File No. 005-78033).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(31)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.28 to Form S-1/A filed by the Company on September 17, 2018 (Commission File No. 333-225193).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.26 to Form 8-K filed by the Company on October 3, 2018 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Company on April 17, 2020 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(34)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.21 to Form 10-K filed by the Company on March 18, 2021 (Commission File No. 000-32929).</span></td></tr>

<tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Company on December 20, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.2 to Form 8-K filed by the Company on December 20, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(37)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.3 to Form 8-K filed by the Company on December 20, 2021 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(38)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 to Form 10-Q filed by the Company on August 15, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.2 to Form 10-Q filed by the Company on August 15, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(40)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.3 to Form 10-Q filed by the Company on August 15, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 to Form 10-Q filed by the Company on November 14, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(42)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.1 to Form 8-K filed by the Company on November 30, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 10.2 to Form 8-K filed by the Company on November 30, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated by reference to Exhibit 21.1 to Form 10-K filed by the Company on March 31, 2022 (Commission File No. 000-32929).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management contract, compensatory plan or arrangement.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish copies of such omitted materials supplementally upon request by the SEC.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
17. Undertakings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;The
undersigned Registrant hereby undertakes:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;To
include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;To
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-
effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in
the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation
of Registration Fee&#8221; table in the effective registration statement;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;To
include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided,
however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;That
for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and this offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&#160;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&#160;That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) (&#167; 230.424(b)(3) of this chapter) shall be deemed to be part of the
registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on
Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required
by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier
of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the
offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date
an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the
registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such effective date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&#160;That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser in the initial distribution of the securities,
the undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration
statement, regardless of the method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser
by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered
to offer or sell such securities to such purchaser:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#160;Any
preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#160;Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the
undersigned Registrant;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#160;The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrant
or its securities provided by or on behalf of the undersigned Registrant; and</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;Any
other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#160;The
undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#160;Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the provisions described in Item 6 hereof, or otherwise, the Registrant has been advised that in the opinion
of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="poa_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-1 and has duly caused this registration statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of San Jose, State of California, on December 15, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PERASO
    INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&#160;James
     Sullivan</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>James
     Sullivan</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Chief&#160;Financial
    Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KNOW
ALL MEN BY THESE PRESENT</b>, that each person whose signature appears below constitutes and appoints Ronald Glibbery and James  Sullivan
and each of them, any of whom may act without the joinder of the other, his true and lawful attorneys-in-fact and agents with full power
of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments
(including post-effective amendments) to this registration statement, and to sign any registration statement for the same offering covered
by this registration statement that is to be effective on filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended,
and all post-effective amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform
each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person,
hereby ratifying and confirming that said attorneys-in-fact and agents or their or his substitute or substitutes, may lawfully do or
cause to be done by virtue hereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the
capacities and on the dates indicated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; padding-right: 0; text-align: justify; padding-left: 0; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202"><b>Signature</b></span></td>
    <td style="padding: 0 0 1.5pt; width: 1%">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0; padding-right: 0; padding-left: 0; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202"><b>Title</b></span></td>
    <td style="padding: 0 0 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; padding-top: 0; padding-right: 0; padding-left: 0; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202"><b>Date</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0; padding-right: 0; text-align: justify; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">/s/&#160;Ronald Glibbery</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Chief&#160;Executive&#160;Officer&#160;and&#160;Director</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">December 15, 2022</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Ronald Glibbery</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">(principal&#160;executive&#160;officer)</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0; padding-left: 0; padding-right: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-left: 0; padding-right: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">/s/&#160;James&#160;Sullivan&#160;&#160;</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Chief&#160;Financial&#160;Officer</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">December 15, 2022</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">James&#160;Sullivan</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">(principal&#160;financial&#160;and&#160;accounting&#160;officer)</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-left: 0; padding-right: 0">&#160;</td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">/s/&#160;Daniel Lewis</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Director</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">December 15, 2022</span></td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Daniel Lewis</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">/s/&#160;Ian McWalter</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Director</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">December 15, 2022</span></td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Ian McWalter</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">/s/&#160;Andreas Melder</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Director</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">December 15, 2022</span></td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Andreas Melder</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">/s/ Robert Y. Newell</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Director</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">December 15, 2022</span></td></tr>
  <tr>
    <td style="padding-top: 0; vertical-align: top; padding-left: 0; padding-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010202">Robert Y. Newell</span></td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="padding-top: 0; padding-right: 0; padding-left: 0">&#160;</td>
    <td style="text-align: center; padding-top: 0; vertical-align: top; padding-right: 0; padding-left: 0">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-8</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0000890394</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="prso-20221215.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><xbrli:context id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbrTOC3cekIpK8k2xuXaxqL/ZXEwWLGMiEsnJgxZhUsDht5+e8B0+v1+o2MiU5UqakhVH+UNQm0+DAmTZwEiS39O5Xqxv37qp8OgT8Lz4MUKF88kI3NA4fsPw0mPQL4H24xhD3M3yVTe90SNVKg8ViwiaVMoDLxY5M=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000890394</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-14</xbrli:startDate>
    <xbrli:endDate>2022-12-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea170067ex5-1_perasoinc.htm
<DESCRIPTION>OPINION OF MITCHELL SILBERBERG & KNUPP LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mitchell Silberberg <FONT STYLE="font-family: Times New Roman, Times, Serif">&amp;</FONT>
Knupp llp</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">A Law Partnership Including Professional Corporations&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">December 15, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Peraso Inc.<BR>
2309 Bering Dr.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Jose, California 95131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">Re:</TD><TD><U>Registration Statement on Form S-1</U></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to
Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the preparation and filing of the Company&rsquo;s
registration statement on Form S-1 (the &ldquo;<U>Registration Statement</U>&rdquo;), under the Securities Act of 1933, as amended (the
&ldquo;Act&rdquo;), filed by the Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;). The Registration
Statement relates to the resale from time to time by the selling stockholder <FONT STYLE="background-color: White">of the Company</FONT>
named in the Registration Statement (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of up to 3,675,000 shares of the Company&rsquo;s common
stock (&ldquo;<U>Warrant Shares</U>&rdquo;), par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), issuable upon the exercise
of the purchase warrants (the &ldquo;<U>Purchase Warrants</U>&rdquo;) that were issued pursuant to the Securities Purchase Agreement,
dated November 28, 2022 by and between the Company and the Selling Stockholder (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is delivered
to you pursuant to Item 16(a) of Form S-1 and Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to
any matter pertaining to the contents of the Registration Statement, the prospectus or any prospectus supplement other than as expressly
stated herein with respect to the issuance of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection therewith, we
have examined and relied upon original, certified, conformed, photostat or other copies of (a) the Amended and Restated Articles of Incorporation
and the Bylaws of the Company; (b) resolutions of the Board of Directors of the Company; (c) the Registration Statement and the exhibits
thereto; (d) the Purchase Agreement and (e) such corporate records of the Company, certificates of public officials, certificates of officers
of the Company and other documents, agreements and instruments as we have deemed necessary as a basis for the opinions herein contained.
In all such examinations, we have assumed the genuineness of all signatures on original documents, and the conformity to originals or
certified documents of all copies submitted to us as conformed, photostat or other copies. In passing upon certain corporate records and
documents of the Company, we have necessarily assumed the correctness and completeness of the statements made or included therein by the
Company, and we express no opinion thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have further assumed the
legal capacity of natural persons, and we have assumed that each party to the documents we have examined or relied on (other than the
Company) has the legal capacity or authority and has satisfied all legal requirements that are applicable to that party to the extent
necessary to make such documents enforceable against that party. We have also assumed that all of the shares of Common Stock issuable
or eligible for issuance pursuant to exercise of the Purchase Warrants following the date hereof will be issued for not less than par
value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: Black 1.5pt solid; width: 60%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1.5pt solid; width: 40%; text-align: left; font-size: 10pt"><FONT STYLE="font-size: 8pt">437 Madison
Ave., 25th Floor, New York, New York 10022-7001<BR> Phone:&nbsp;&nbsp;(212) 509-3900&nbsp;&nbsp;Fax:&nbsp;&nbsp;(212) 509-7239&nbsp;&nbsp;Website:&nbsp;WWW.MSK.COM</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="ex5-1_001.jpg" ALT=""></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">December 15, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the foregoing, we
are of the opinion that the Warrant Shares have been duly authorized by all necessary corporate action of the Company, and, upon (i) the
due execution by the Company and registration by its transfer agent of such Warrant Shares, (ii) the issuance and delivery of such Warrant
Shares upon exercise of the Purchase Warrants in accordance with the terms thereof and (iii) receipt by the Company of the consideration
therefor in accordance with the terms of the Purchase Warrants, the Warrant Shares will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion is opining upon
and is limited to the Delaware General Corporation Law as such laws presently exist and to the facts as they presently exist. We express
no opinion with respect to the effect or applicability of the laws of any other jurisdiction. We assume no obligation to revise or supplement
this opinion letter should the laws of such jurisdiction be changed after the date hereof by legislative action, judicial decision, or
otherwise.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the
use of this opinion letter as an exhibit to the Registration Statement, to the use of our name as the Company&rsquo;s counsel and to all
references made to us in the Registration Statement and in the prospectus forming a part thereof. In giving this consent, we do not admit
that we are in the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations promulgated
thereunder. This opinion is given as of the effective date of the Registration Statement, and we are under no duty to update the opinion
contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ MITCHELL SILBERBERG &amp; KNUPP LLP</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea170067ex23-1_perasoinc.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM-WEINBERG & CO., P.A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Consent of Independent Registered Public Accounting
Firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
in this Registration Statement on Form S-1 of Peraso Inc. of our report, dated March 31, 2022, relating to their consolidated financial
statements, which appears in the Annual Report on Form 10-K filed on March 31, 2022, and to the reference to our firm under the heading
&ldquo;Experts&rdquo; in the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>/s/ Weinberg &amp; Company, P.A.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WEINBERG &amp; COMPANY, P.A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Los Angeles, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">December 15, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea170067ex-fee_perasoinc.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Calculation of Filing Fee Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%; font-size: 10pt; text-align: center"><B>Form S-1</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center; width: 5%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">Form Type</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><B>Peraso Inc.</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">(Exact Name of Registrant as Specified in its Charter)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: center"><B>Table 1: Newly Registered Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Security <BR>Type</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Security <BR>Class Title</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Fee <BR>Calculation <BR>or Carry <BR>Forward <BR>Rule</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Amount <BR>Registered <BR>(1)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Proposed <BR>Maximum <BR>Offering <BR>Price Per <BR>Unit<BR>

    (2)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Maximum <BR>Aggregate <BR>Offering Price <BR>(2)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Fee Rate</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Amount of <BR>Registration <BR>Fee</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 10%; text-align: left; padding-bottom: 1.5pt">Fees to be Paid</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 11%; text-align: center; padding-bottom: 1.5pt">Equity</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center; padding-bottom: 1.5pt">Common Stock, $0.001 par value per share</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">457(g)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">3,675,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1.36</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">4,998,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.00011020</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">550.77</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; padding-bottom: 1.5pt">Total Offering Amounts</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4,998,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">550.77</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; padding-bottom: 1.5pt">Total Fees Previously Paid</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; padding-bottom: 1.5pt">Total Fee Offsets</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; padding-bottom: 1.5pt">Net Fee Due</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">550.77</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Represents 3,675,000 shares of the registrant&rsquo;s common
stock issuable upon the exercise of warrants issued pursuant to a Securities Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;),
dated November 28, 2022, by the selling stockholder named in the registration statement, from time to time, upon the terms and subject
to the satisfaction of the conditions set forth in the Purchase Agreement. The registration statement also includes an indeterminate
number of shares that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar
transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Estimated solely for the purpose of calculating the registration
fee pursuant to Rule 457(g) under the Securities Act, based on an exercise price per share of $1.36 applicable to the shares issuable
upon the exercise of the warrants.</TD>
</TR></TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  P .\# 2(  A$! Q$!_\0
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M_@Z(_8-?I\,OVD?Q\+> AZ_]5$]JL1_\'/W[",I"K\,_VC@S,% ;POX#&22
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MQ3J_*_\ X(_?M8#]J+]C_P )0Z[J7VWXD?!M;3X8^.!/*9+Z]M]*LH_^$/\
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M,\S7P]XVKYI5G3BJ%+$8N/#U.IP[G&(]V$GC:>*PM'&R2K5[NK5G/U;]O/\
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2#\9+$O%1PU?$8?!X?!O^T?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  C &X# 2(  A$! Q$!_\0
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MF","-KB\G;9;6L?WYG]!Z =2QX I-9UF+288P(FN+RX;9;6L9^>9OZ =2QX
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C:I9P6GBL:C;*8KJXM#',Z,1Y@5AMW#."1DX.,X.*** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>prso-20221215.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Dec 15 21:50:15 UTC 2022 -->
<xs:schema elementFormDefault="qualified" xmlns:prso="http://www.perasoinc.com/20221215" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://www.perasoinc.com/20221215" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="prso-20221215_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="prso-20221215_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="prso-20221215_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbrTOC3cekIpK8k2xuXaxqL/ZXEwWLGMiEsnJgxZhUsDht5+e8B0+v1+o2MiU5UqakhVH+UNQm0+DAmTZwEiS39O5Xqxv37qp8OgT8Lz4MUKF88kI3NA4fsPw0mPQL4H24xhD3M3yVTe2TWLDkqH2ZZWqONETXD2Vw=] CSR-->
      <link:roleType roleURI="http://www.perasoinc.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="prso_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>prso-20221215_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Dec 15 21:50:15 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="prso-20221215.xsd#DocumentAndEntityInformation" roleURI="http://www.perasoinc.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.perasoinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbrTOC3cekIpK8k2xuXaxqL/ZXEwWLGMiEsnJgxZhUsDht5+e8B0+v1+o2MiU5UqakhVH+UNQm0+DAmTZwEiS39O5Xqxv37qp8OgT8Lz4MUKF88kI3NA4fsPw0mPQL4H24xhD3M3yVTe0obpelmvtYIkoA2pzKtzqw=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="9" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>prso-20221215_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Dec 15 21:50:15 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbrTOC3cekIpK8k2xuXaxqL/ZXEwWLGMiEsnJgxZhUsDht5+e8B0+v1+o2MiU5UqakhVH+UNQm0+DAmTZwEiS39O5Xqxv37qp8OgT8Lz4MUKF88kI3NA4fsPw0mPQL4H24xhD3M3yVTe6loMBmHjmgfMgDqDae64xQ=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>prso-20221215_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Dec 15 21:50:15 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="prso-20221215.xsd#DocumentAndEntityInformation" roleURI="http://www.perasoinc.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.perasoinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="prso-20221215.xsd#prso_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbrTOC3cekIpK8k2xuXaxqL/ZXEwWLGMiEsnJgxZhUsDht5+e8B0+v1+o2MiU5UqakhVH+UNQm0+DAmTZwEiS39O5Xqxv37qp8OgT8Lz4MUKF88kI3NA4fsPw0mPQL4H24xhD3M3yVTexARB2UUxSi7DBahSNJC8Dc=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139669278070096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PERASO INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000890394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0291941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>ea170067-s1_perasoinc_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prso-20221215.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000890394</identifier>
        </entity>
        <period>
            <startDate>2022-12-14</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="c0">PERASO INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">77-0291941</dei:EntityTaxIdentificationNumber>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0">0000890394</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M-E4DYPH]&09;B(S5'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T'D&6A^[
M](2.(2X-PW.D0XMAU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y1G"=P) :
M;)-6P7@H]+BB[H-5CX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#\%&MA1H#
MV#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%     @
M"8>/520>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ "8>/50=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  )AX]5>T?-
M?NX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  )AX]5F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  F'CU4P0,Z_V@(  -((
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  )AX]5GZ ;\+$"  #B#   #0              @ $="P
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  F'CU67BKL<P    !,"   +
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4!08     "0 ) #X"  !^$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>9</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea170067-s1_perasoinc.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.perasoinc.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1" original="ea170067-s1_perasoinc.htm">ea170067-s1_perasoinc.htm</File>
    <File>ea170067ex-fee_perasoinc.htm</File>
    <File>ea170067ex23-1_perasoinc.htm</File>
    <File>ea170067ex5-1_perasoinc.htm</File>
    <File>prso-20221215.xsd</File>
    <File>prso-20221215_def.xml</File>
    <File>prso-20221215_lab.xml</File>
    <File>prso-20221215_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea170067-s1_perasoinc.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "prso-20221215_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea170067-s1_perasoinc.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prso-20221215_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prso-20221215_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prso-20221215.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 12,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 9,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "prso",
   "nsuri": "http://www.perasoinc.com/20221215",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea170067-s1_perasoinc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.perasoinc.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea170067-s1_perasoinc.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.perasoinc.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "prso_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.perasoinc.com/20221215",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-22-080156-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-080156-xbrl.zip
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MT'31^%S*6^(0JWUR0B*I$:BO%'7!( ')N4C>0-\%;YE,D6KKOF/_7V+"F:E
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MQ^E%4+5$X4;K(/X$B6LZ<5=:F_3-TE45EA:(33M>QG,SJ6MM*S"3FFO/XH'
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MHD[GZ=G2#M=]4O.ZK8V/[E"D#9NPC0FB1.I<?Z$J*64(I#>)U04YX3\ X[E
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M8!T1K+S*M<*X/*OFW@M43YAS4:EY#GS9U%UI;1U(A=<S/430,4Z)X>ZV+DE
MY?=L-V:0JMU@HY[[MH)CB_9[0G\2O?=E,T'-HSXFB1ZF140"U)9#L5E 5:K#
M"==_^R[INS0AZ;@+;'A>)PM,5UO% N_PN"F 3&F_\C:/4_JZ07>KF<17PU>[
M"SN"(3_RD*8+@5DE[2&8'N6<O@>SNV7;$M\F);[C[V-=NND78O4V*3BM3)]Q
M[ [56I2/TU&F]U?/&/L"E*F_K75V=JJ^M(WFWW.^'-%WU[INW3Y\?<NFD3T9
MC48ZY!8"M169-FH];?L_A+5N5R5H;]0@RVB:L]Y0?1W.!IN(W(]*=;=@D%^
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M7;N=).-:!"YH0QNOO7KB)TU97XXC9%/BO@6>L4H)D0HFCME6*K/.F-8W+SG
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M>=W9"$<8X[]<[ +V\!H[XEX+XCX+M7)YH-J$L)3L1SGXI;KBV<WKE&$T5:X
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ML3TP%YBW3N8^L67Z^N^@P"/):XSDN6NHKG\Z.#I +S?%H$<>7:X:(.+1--X
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M,A[GI$I+T<$ G7KTG.NQU%/.J^KP03)B_<4]+7^>(1WNS0]PH ,FH\%MWOK
M*O&Z\T2WGA_WLB'.?>QY.7XXF,2EW@)V)7;\>()B2:*G ;L.#@N@'IH&3BF4
M@HFPBYUZ8'I8,#;\GET[)H B!L(NGE"L[D3H;%U/47BHC?=,I8O-H.?8RFD
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M93ASO:F\)P:Q(A)08<<2]H$Q+\#0;E>D<GNZ[ W[T$)X",1NLXQ<^:,+[46
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M>*"_T(N >2QP#D(._47<%:/8#W2KR>?%K!N!MVMV]Z5#W@+(M[\1\I41_N7
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M;*= CIATIQ'!$.7<$EWQ-P&L1.INXJ<,'>$87I)@BC"#DAN%'MTN+D<?XKT
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MRVK<#T[L#_;XMRNO:UQ^_.W=3><W_\YW?OL0G;R__Z/YX<?_TX\O+X!4X0I
M@K'[\0C8["/YH8_R!OL5QCI=.,!AD*:CUX>'=W=W!XG7.[B);@^/S]X5L:+\
M8[QL6NJPM):R_@@P*')+ZR>I$Z=81O0&$6/?A/^7K\^_T_GKE;.XQ1\U\Y79
M-^INY,J(O@5D$;@E4>E0I5-X7BNPQ,/KR!VC$C!(A\&;_P]02P,$%     @
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M##&GDP7[T^6G^##"7P[-JJ[ RYU879UO4$L#!!0    (  F'CU4A&!4\>0L
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MK#)!<3R(T+!GG_5XZZ_-_<@"W4SY 3//Y-JMRY<GM0X2AG5[?AV:]77I.TL
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M-,:A!W" 0TS%I0S;P$,O"435F"9>0(8$^P:0>5%>B1F/JL8&G5BRYQ&A2/&
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MQ%D0(MTOI5O-[9]'L=23%*Y?_;K=_P%02P,$%     @ "8>/56H<L#E]!
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M[)]=R<KS"F;N<(N"YX&M/OVS@67)_P!02P,$%     @ "8>/5=B-Z( X!
M+Q8  !4   !P<G-O+3(P,C(Q,C$U7W!R92YX;6S56%U3VS@4?>^OT'I?=H<Q
M_B*;CR%T@D-H(($6VQ3H='8<6['5V)*1G,3AUZ]D)RP.$!J2&>#-5FZ.SCWG
MZDK6_N<LCL $4H8(;DK:KBH!B#WB(QPT)<>26Y;9[4J?#P#XM/^'+(-CB"%U
M4^B#P0R8)$XL#P&;NI@-"8W!7VG\-Y!!F*9)0U&FT^FNQV.8ARAD9$P]R,0
MD&4.N( T*12 #6"'8]"&'M J0-<:%;7!'QS;!+JJZ\5?/NU'"(\&+H. \\:L
M*3V8*1O0:)?00-%5U5 6@5(1V<C$0"E^:N316KU>5_)?[T,9>BJ0PVK*5;]G
M>2&,71EAEKK8$Q,PU&#Y8(]X;IHK^2(O\&R$>),78;(8DC5=-K3=C/E2H1L
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MK]6);]$!M<]-PX.C;G):&^G9^,K-;GO*S=71]'OON(^.&#X)LIO08>TPK>S
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M87-O:6YC+FAT;5!+ 0(4 Q0    (  F'CU5:]^Y[6 8  $@R   <
M      "  =VN  !E83$W,# V-V5X+69E95]P97)A<V]I;F,N:'1M4$L! A0#
M%     @ "8>/53IBXX@@ @  00<  !P              ( !;[4  &5A,3<P
M,#8W97@R,RTQ7W!E<F%S;VEN8RYH=&U02P$"% ,4    "  )AX]5(1@5/'D+
M  #R+   &P              @ ')MP  96$Q-S P-C=E>#4M,5]P97)A<V]I
M;F,N:'1M4$L! A0#%     @ "8>/57%WEV]8-   KS4   T
M ( !>\,  &EM86=E7S P,2YJ<&=02P$"% ,4    "  )AX]5N#%UH2D$  "U
M#   $0              @ '^]P  <')S;RTR,#(R,3(Q-2YX<V102P$"% ,4
M    "  )AX]5:ARP.7T$  #C%@  %0              @ %6_   <')S;RTR
M,#(R,3(Q-5]D968N>&UL4$L! A0#%     @ "8>/53;7^!7(!   6"(  !4
M             ( !!@$! '!R<V\M,C R,C$R,35?;&%B+GAM;%!+ 0(4 Q0
M   (  F'CU78C>B . 0  "\6   5              "  0$& 0!P<G-O+3(P
D,C(Q,C$U7W!R92YX;6Q02P4&      D "0!G @  ; H!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
